These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24103703)

  • 1. Multi-nutrient supplement improves hormone ratio associated with cancer risk.
    Bazzan AJ; Zabrecky GP; Newberg AB
    J Transl Med; 2013 Oct; 11():252. PubMed ID: 24103703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of the plasma ratio of 2-hydroxyestrone to 16alpha-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups.
    Jernström H; Klug TL; Sepkovic DW; Bradlow HL; Narod SA
    Carcinogenesis; 2003 May; 24(5):991-1005. PubMed ID: 12771045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating estrogen metabolites and risk for breast cancer in premenopausal women.
    Arslan AA; Shore RE; Afanasyeva Y; Koenig KL; Toniolo P; Zeleniuch-Jacquotte A
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2273-9. PubMed ID: 19661086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.
    Zeleniuch-Jacquotte A; Shore RE; Afanasyeva Y; Lukanova A; Sieri S; Koenig KL; Idahl A; Krogh V; Liu M; Ohlson N; Muti P; Arslan AA; Lenner P; Berrino F; Hallmans G; Toniolo P; Lundin E
    Br J Cancer; 2011 Oct; 105(9):1458-64. PubMed ID: 21952628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    J Natl Cancer Inst; 1999 Jun; 91(12):1067-72. PubMed ID: 10379970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.
    Muti P; Bradlow HL; Micheli A; Krogh V; Freudenheim JL; Schünemann HJ; Stanulla M; Yang J; Sepkovic DW; Trevisan M; Berrino F
    Epidemiology; 2000 Nov; 11(6):635-40. PubMed ID: 11055622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen metabolites and the risk of breast cancer in older women.
    Cauley JA; Zmuda JM; Danielson ME; Ljung BM; Bauer DC; Cummings SR; Kuller LH
    Epidemiology; 2003 Nov; 14(6):740-4. PubMed ID: 14569192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
    Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers.
    Nikitina D; Llacuachaqui M; Sepkovic D; Bradlow HL; Narod SA; Kotsopoulos J
    Fam Cancer; 2015 Jun; 14(2):281-6. PubMed ID: 25613194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels.
    Klug TL; Bågeman E; Ingvar C; Rose C; Jernström H
    Mol Genet Metab; 2006 Dec; 89(4):381-9. PubMed ID: 16978896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between physical activity and 2-hydroxyestrone, 16alpha-hydroxyestrone, and the 2/16 ratio in premenopausal women (United States).
    Bentz AT; Schneider CM; Westerlind KC
    Cancer Causes Control; 2005 May; 16(4):455-61. PubMed ID: 15953988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary excretion of 2-hydroxyestrone but not 16alpha-hydroxyestrone in premenopausal women during a soya diet containing isoflavones.
    Lu LJ; Cree M; Josyula S; Nagamani M; Grady JJ; Anderson KE
    Cancer Res; 2000 Mar; 60(5):1299-305. PubMed ID: 10728690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary equol excretion in relation to 2-hydroxyestrone and 16alpha-hydroxyestrone concentrations: an observational study of young to middle-aged women.
    Atkinson C; Skor HE; Dawn Fitzgibbons E; Scholes D; Chen C; Wähälä K; Schwartz SM; Lampe JW
    J Steroid Biochem Mol Biol; 2003 Jul; 86(1):71-7. PubMed ID: 12943746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.
    Barba M; Yang L; Schünemann HJ; Sperati F; Grioni S; Stranges S; Westerlind KC; Blandino G; Gallucci M; Lauria R; Malorni L; Muti P
    J Exp Clin Cancer Res; 2009 Oct; 28(1):135. PubMed ID: 19814782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
    Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
    Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment.
    Westerlind KC; Gibson KJ; Wolfe P
    Steroids; 1999 Mar; 64(3):233-43. PubMed ID: 10400385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.
    Falk RT; Rossi SC; Fears TR; Sepkovic DW; Migella A; Adlercreutz H; Donaldson J; Bradlow HL; Ziegler RG
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):81-7. PubMed ID: 10667467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hormonal association between estrogen metabolism and proliferative thyroid disease.
    Chan EK; Sepkovic DW; Yoo Bowne HJ; Yu GP; Schantz SP
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):893-900. PubMed ID: 16730526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary estrogen metabolites and prostate cancer: a case-control study in the United States.
    Muti P; Westerlind K; Wu T; Grimaldi T; De Berry J; Schünemann H; Freudenheim JL; Hill H; Carruba G; Bradlow L
    Cancer Causes Control; 2002 Dec; 13(10):947-55. PubMed ID: 12588091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study: effect of 3,3'-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer.
    Dalessandri KM; Firestone GL; Fitch MD; Bradlow HL; Bjeldanes LF
    Nutr Cancer; 2004; 50(2):161-7. PubMed ID: 15623462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.